DelMar Pharma Cash Flow - Annual (NASDAQ:DMPI)

Add to My Stocks
$0.74 $0.04 (5.71%) DMPI stock closing price Sep 19, 2018 (Closing)

The DelMar Pharma cash flow statement is one of the three reports that the company generates every quarter. Financials statements like the DelMar Pharma income statement and DelMar Pharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. The cash flow statement is essetial while conducting the DelMar Pharma cash flow analysis and can be used to measure the operating performance of DelMar Pharma compared to various industry peers like EYEG stock and CPMD stock. DelMar Pharma has a negative cash and cash equivalents change of $-.

View details of DelMar Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jul - Jun20172016201520142013201220112010
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--------
Net Increase (Decrease) in Assets Liabilities-0.47M-0.11M--0.37M-0.62M--0.01M-
Cash From (used in) Discontinued Operations--------
Other Adjustments Net-3.82M--6.75M11.46M---
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--------
Acquisition Disposition of Subsidiaires--------
Increase (Decrease) in Investments--------
Other Cash Inflow (Outflow) from Investment Activities-0.02M-0.01M------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares8.47M9.57M1.4M2.48M9.63M---
Issuance (Repayment) of Debt Securities--------
Increase (Decrease) in Bank & Other Borrowings--------
Payment of Dividends & Other Cash Distributions-0.01M-0.01M-0.01M-----
Other Cash from (used by) Financing Activities---0.55M-----
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year6.15M1.75M4.75M6.28M----
Cash & Equivalents at Year End6.58M6.15M1.75M4.75M6.28M---
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

While DelMar Pharma stock price history provides the price history of a stock, DelMar Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • DelMar Pharma had a Net Change in Cash and Cash Equivalents of $- for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the DelMar Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: DelMar Pharma reported a negative operating cash flow of $-8.01M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.02M for DMPI stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $8.46M for DelMar Pharma.

Key Financial Ratios For DelMar Pharma Cash Flow